Dr. Vargas on Research With Proton Therapy in Prostate Cancer

In Partnership With:

Carlos E. Vargas, MD, discusses research with proton therapy in prostate cancer.

Carlos E. Vargas, MD, radiation oncologist, Mayo Clinic, discusses research with proton therapy in prostate cancer.

Proton therapy is not widespread in prostate cancer. However, ongoing research is being done to refine its use before it is introduced to the paradigm, says Vargas. Moreover, investigators are evaluating the use of FLASH proton radiotherapy, in which high doses of radiation are delivered in short frequencies, says Vargas.

The first report of activity with FLASH proton therapy was reported in mice in 2014. Few centers around the world have access to FLASH therapy. However, if ongoing research pans out and shows favorable outcomes with the approach, proton therapy will become one of the major players in radiation therapy in prostate cancer, concludes Vargas.

Related Videos
Brian Henick, MD
Abhinav Deol, MD
Veronika Bachanova, MD, PhD
Walter M. Stadler, MD
Susan Domchek, MD, FASCO
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Amy L. Cummings, MD, thoracic oncologist, assistant professor of medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center
Amandeep Godara, MBBS
Eunice Wang, MD
Yvonne Chao, MD, PhD
Related Content